Creating a calm, distraction-free eating environment can help you naturally slow down and tune into hunger and satiety cues
Although serious side effects are rare, they may include pancreatitis or gallbladder complications
Older adults may be more sensitive to gastrointestinal side effects and more vulnerable to the nutritional consequences of significantly reduced food intake
WeightWatchers GLP-1 program costs $25 per month for a membership, plus the price of medication, which varies depending on the prescription and type of GLP-1
This study aims to investigate whether semaglutide can reduce the progression of noncalcified coronary atherosclerotic plaque volume, as measured by serial coronary computed tomography angiography (CTA), over a one-year period compared to a placebo, in individuals with diabetes

Introduction Evidence from observational studies shows that use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with various health benefits,1 including reduced risks of incident alcohol use disorder23 and incident cannabis use disorder4 and reduced frequency of healthcare encounters for tobacco use disorder.5 However, much less is known about the association between GLP-1 receptor agonists and risks of developing other substance use disorders (SUDs), such as opioid use disorder and stimulant use disorder.6 Observational studies within populations with a pre-existing SUD have also emerged suggesting that use of GLP-1 receptor agonists is associated with reduced risks of adverse events such as opioid overdose,78 alcohol intoxication,7 and risk of hospital admission for alcohol use disorder.9 While the evidence base is growing, it does not comprehensively include all common SUDs